Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 09, 2024

BUY
$0.15 - $0.37 $6,130 - $15,123
40,873 New
40,873 $6,000
Q4 2023

Feb 26, 2024

BUY
$0.12 - $0.64 $19,546 - $104,246
162,885 New
162,885 $35,000
Q2 2023

Jul 27, 2023

BUY
$0.35 - $0.72 $31,604 - $65,014
90,298 New
90,298 $33,000
Q4 2022

Feb 15, 2023

BUY
$0.46 - $42.69 $54,201 - $5.03 Million
117,830 Added 448.62%
144,095 $72,000
Q3 2022

Nov 07, 2022

SELL
$0.63 - $33.0 $41,382 - $2.17 Million
-65,686 Reduced 71.44%
26,265 $17,000
Q2 2022

Aug 09, 2022

BUY
$0.63 - $0.96 $57,929 - $88,272
91,951 New
91,951 $73,000
Q1 2022

May 17, 2022

SELL
$0.5 - $1.06 $42,356 - $89,794
-84,712 Closed
0 $0
Q4 2021

Feb 17, 2022

SELL
$0.92 - $1.22 $134,460 - $178,306
-146,153 Reduced 63.31%
84,712 $86,000
Q3 2021

Nov 12, 2021

BUY
$0.67 - $1.51 $154,679 - $348,606
230,865 New
230,865 $300,000
Q1 2021

May 19, 2021

SELL
$0.96 - $1.74 $45,190 - $81,907
-47,073 Closed
0 $0
Q4 2020

Feb 24, 2021

BUY
$0.76 - $1.47 $35,775 - $69,197
47,073 New
47,073 $64,000
Q2 2020

Aug 07, 2020

SELL
$0.52 - $0.92 $76,321 - $135,030
-146,772 Closed
0 $0
Q4 2019

Feb 04, 2020

BUY
$0.63 - $2.27 $92,466 - $333,172
146,772 New
146,772 $333,000
Q3 2019

Nov 20, 2019

SELL
$0.59 - $0.9 $17,532 - $26,744
-29,716 Closed
0 $0
Q2 2019

Aug 13, 2019

SELL
$0.79 - $1.11 $68,666 - $96,481
-86,920 Reduced 74.52%
29,716 $25,000
Q1 2019

Apr 12, 2019

BUY
$0.6 - $1.41 $31,111 - $73,112
51,853 Added 80.04%
116,636 $127,000
Q4 2018

Jan 16, 2019

BUY
$0.53 - $1.11 $34,334 - $71,909
64,783 New
64,783 $39,000
Q1 2018

May 14, 2018

SELL
$0.76 - $1.32 $80,670 - $140,112
-106,146 Closed
0 $0
Q4 2017

Feb 09, 2018

BUY
$1.1 - $1.54 $65,106 - $91,149
59,188 Added 126.04%
106,146 $123,000
Q3 2017

Nov 15, 2017

BUY
$1.19 - $1.43 $55,880 - $67,149
46,958
46,958 $0

Others Institutions Holding MTNB

About Matinas BioPharma Holdings, Inc.


  • Ticker MTNB
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 216,864,992
  • Market Cap $143M
  • Description
  • Matinas BioPharma Holdings, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of various product candidates. It develops products using its lipid nanocrystal (LNC) platform technology. The company's LNC delivery technology platform utilizes lipid nano-crystals for the delivery of small molecules, nucleic ...
More about MTNB
Track This Portfolio

Track Virtu Financial LLC Portfolio

Follow Virtu Financial LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Virtu Financial LLC, based on Form 13F filings with the SEC.

News

Stay updated on Virtu Financial LLC with notifications on news.